RiteMED Co-amoxiclav Indications/Uses

625 mg: For the treatment of common bacterial infections where oral therapy is indicated, including: upper respiratory tract infections (including ENT): sinusitis, tonsillitis, otitis media.
Skin and soft tissue infections: boils/abscesses, cellulitis, wound infections, intra-abdominal sepsis.
Lower respiratory tract infections: acute and chronic bronchitis, pneumonia, lung abscess.
Genitourinary tract infections: cystitis, urethritis, pyelonephritis, septic abortion, pelvic infection, gonorrhea.
Other infections: osteomyelitis, septicemia, peritonitis, post-operative infections.
1 g: Amoxicillin/clavulanic acid is indicated for the treatment of the following infections in adults and children (see Dosage & Administration, Precautions, and Pharmacology: Pharmacodynamics under Actions): Acute bacterial sinusitis (adequately diagnosed).
Acute otitis media.
Acute exacerbations of chronic bronchitis (adequately diagnosed).
Community-acquired pneumonia.
Cystitis.
Pyelonephritis.
Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.
Bone and joint infections, in particular osteomyelitis.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.